Harmony Biosciences Holdings (HRMY) EBITDA (2019 - 2026)
Harmony Biosciences Holdings (HRMY) recorded EBITDA of $95.28 million in Q2 2026, up 76.0% from $54.15 million a year earlier and up 120.3% from the prior quarter.
Powered by 
Analysis
Harmony Biosciences Holdings (HRMY) EBITDA (2019 - 2026) Analysis & Trends
On a TTM basis, Harmony Biosciences Holdings' EBITDA came in at $255.99 million as of Jun 30, 2026, up 4.2% year-over-year; for FY2025, it came in at $233.8 million, up 8.8% from FY2024.
- Annual EBITDA has a five-year compound annual growth rate of 53.7% (FY2020 to FY2025).
- Across earlier years, EBITDA came in at $214.94 million in FY2024 (-0.7%), $216.39 million in FY2023 (+50.7%), $143.57 million in FY2022 (+35.0%) and $106.37 million in FY2021 (+290.7%).
- The Q2 2026 figure is the highest quarterly EBITDA in data going back to Q4 2019.
- On a year-over-year basis, EBITDA rose in five of the last eight quarters, with growth averaging 19.9%.
- Peak year-over-year performance for EBITDA in the last five years was growth of 293.1% in Q3 2023, against a decline of 48.3% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $43.26 million (Q1 2026), $45.99 million (Q4 2025) and $71.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Harmony Biosciences Holdings | 2.28 Bn | -473.07 Mn | 198.08 Mn | 95.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95.28 Mn |
| Mar 31, 2026 | 43.26 Mn |
| Dec 31, 2025 | 45.99 Mn |
| Sep 30, 2025 | 71.46 Mn |
| Jun 30, 2025 | 54.15 Mn |
| Mar 31, 2025 | 62.21 Mn |
| Dec 31, 2024 | 61.70 Mn |
| Sep 30, 2024 | 67.68 Mn |
| Jun 30, 2024 | 27.41 Mn |
| Mar 31, 2024 | 58.16 Mn |
| Dec 31, 2023 | 46.32 Mn |
| Sep 30, 2023 | 70.62 Mn |
| Jun 30, 2023 | 52.97 Mn |
| Mar 31, 2023 | 46.49 Mn |
| Dec 31, 2022 | 53.68 Mn |
| Sep 30, 2022 | 17.96 Mn |
| Jun 30, 2022 | 39.17 Mn |
| Mar 31, 2022 | 32.76 Mn |
| Dec 31, 2021 | 33.39 Mn |
| Sep 30, 2021 | 25.73 Mn |
API Access
Harmony Biosciences Holdings EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();